Our experts are here to guide you every step of the way
doi: 10.1016/j.clindermatol.2021.05.010 42 DosedlMJirkovskEMackovKKrmovLKJavorskLPourovJet al
Available from: Kornelius E, Huang JY, Lo SC, Huang CN, Yang YS
A true reaction spreads to new areas, may burn or swell, and worsens with continued use
The standard Phase 2 trial schedule began at 0.5 to 1mg weekly, escalating every 4 weeks through 2mg, 4mg, 8mg, and up to 12mg
Related Healing Research Compounds TB-500 10mg Thymosin Beta-4 Healing Peptide BPC-157 + TB-500 Blend 20mg Dual Healing Stack Wolverine+ Blend 30mg KPV + BPC-157 + TB-500 KPV 10mg Anti-Inflammatory Tripeptide Research ARA-290 10mg Erythropoietin-Derived Peptide Scientific References Sikiric et al